Avinger Inc (NASDAQ: AVGR) is moving higher in the opening session on Tuesday.
Avinger Announces Issuance and Allowance of Seven U.S. Patents
- AVGR announced the issuance and allowance of seven U.S. patents to date in 2021.
- These new U.S. patents include a wide range of claims relating to Avinger’s proprietary optical coherence tomography (OCT) intravascular imaging system and its OCT-guided catheters for the treatment of vascular disease.
- With the addition of these patents and new filings made in 2021, Avinger’s intellectual property portfolio now numbers 182 patents and pending applications, including 41 issued and allowed patents in the U.S. and 76 issued and allowed patents outside the U.S. The portfolio has broad applicability in the areas of atherectomy, CTO-crossing and intravascular imaging for both peripheral and coronary vessels.
“We continue to build our intellectual property portfolio as we expand our pipeline of proprietary products and bring new innovations and improvements to our intravascular imaging platform,” commented Jeff Soinski, Avinger’s President and CEO.
As of 9:51, AVGR stock went up 3.06% to $1.03. The stock has traded 655K shares, compared to its average volume of 4.59 million shares. After opening at $1.02, the stock has moved within a wide range of $1.0100 – 1.0500.